English

AMERICAN BIO MEDICA CORP

EDGAR

ABMC Quarterly report (10-Q) · filed 2023-06-12

129 filing records in this dataset, filed from 1996-12-11 to 2023-06-12. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

164 thousand USD

2023 Q1 · USD

Exact inputs and evidence

Revenue: 164000 USD Source

Operating margin

-129.27%

2023 Q1 · %

Exact inputs and evidence

Operating Income: -212000 USD Source
Revenue: 164000 USD Source

Operating cash flow

-363 thousand USD

2023 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -363000 USD Source

Cash and cash equivalents: 68 thousand USD 2023-03-31 Source
Exact value

68000 USD
Long-term debt including current maturities: 175 thousand USD 2023-03-31 Source
Exact value

175000 USD
Shares outstanding: 48.1 million shares 2023-03-31 Source
Exact value

48098476 shares

Reported share-count change

0.00% · 0 shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

48098476 shares · 2022-03-31· Source
48098476 shares · 2023-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

725 thousand USD

2022-04-01 – 2023-03-31

Exact inputs and evidence

Revenue: 185000 USD · 2022-04-01 – 2022-06-30 Source
Revenue: 209000 USD · 2022-07-01 – 2022-09-30 Source
Revenue: 913000 USD · 2022-01-01 – 2022-12-31 Source
Revenue: 746000 USD · 2022-01-01 – 2022-09-30 Source
Revenue: 164000 USD · 2023-01-01 – 2023-03-31 Source

Net income

850 thousand USD

2022-04-01 – 2023-03-31

Exact inputs and evidence

Net income: -400000 USD · 2022-04-01 – 2022-06-30 Source
Net income: -314000 USD · 2022-07-01 – 2022-09-30 Source
Net income: -1410000 USD · 2022-01-01 – 2022-12-31 Source
Net income: -1093000 USD · 2022-01-01 – 2022-09-30 Source
Net income: 1881000 USD · 2023-01-01 – 2023-03-31 Source

Operating cash flow

-1.12 million USD

2022-04-01 – 2023-03-31

Exact inputs and evidence

Operating cash flow: -82000 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -13000 USD · 2022-01-01 – 2022-03-31 Source
Operating cash flow: -157000 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -82000 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -768000 USD · 2022-01-01 – 2022-12-31 Source
Operating cash flow: -157000 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -363000 USD · 2023-01-01 – 2023-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2023-06-12.

Financial data available through: 2022-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2022-12-31
Operating income: 11 of 11 periods available· newest 2022-12-31
Net income: 11 of 11 periods available· newest 2022-12-31
Operating cash flow: 11 of 11 periods available· newest 2022-12-31
Capital expenditure: 10 of 11 periods available· newest 2021-12-31
Total assets: 6 of 11 periods available· newest 2022-12-31
Total liabilities: 6 of 11 periods available· newest 2022-12-31
Current assets: 6 of 11 periods available· newest 2022-12-31
Current liabilities: 6 of 11 periods available· newest 2022-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2022-12-31
Long-term debt including current maturities: 6 of 11 periods available· newest 2022-12-31
Shares outstanding: 6 of 11 periods available· newest 2022-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-58.8%

Prior period

USD 2.22 million

2021-01-01 – 2021-12-31
Current period

USD 913,000

2022-01-01 – 2022-12-31

Exact inputs and evidence

913000 − 2218000 = -1305000 USD

2218000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
913000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · AMERICAN BIO MEDICA CORP · 2022-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Year-over-year change in Revenue: -1305000 USD Concept: fundies:Revenue Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 913000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495423003260/abmc_10k.htm#941867 Filing: 000165495423003260 Input fundies:Revenue: 2218000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495423003260/abmc_10k.htm#942505 Filing: 000165495423003260
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 947,000

Prior period

−USD 463,000

2021-01-01 – 2021-12-31
Current period

−USD 1.41 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-1410000 − -463000 = -947000 USD

-463000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-1410000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · AMERICAN BIO MEDICA CORP · 2022-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Year-over-year change in Net income: -947000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -1410000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495423003260/abmc_10k.htm#592058 Filing: 000165495423003260 Input fundies:NetIncome: -463000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495423003260/abmc_10k.htm#592782 Filing: 000165495423003260
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 95,000

Prior period

−USD 673,000

2021-01-01 – 2021-12-31
Current period

−USD 768,000

2022-01-01 – 2022-12-31

Exact inputs and evidence

-768000 − -673000 = -95000 USD

-673000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-768000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · AMERICAN BIO MEDICA CORP · 2022-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Year-over-year change in Operating cash flow: -95000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -768000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495423003260/abmc_10k.htm#561109 Filing: 000165495423003260 Input fundies:OperatingCashFlow: -673000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495423003260/abmc_10k.htm#561791 Filing: 000165495423003260
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2022-01-01 – 2022-12-31

Revenue USD 913,000 100% of revenue
Operating costs Derived USD 2.16 million 236% of revenue
Operating income −USD 1.24 million −136% of revenue
Tax, interest and other Derived USD 168,000 18% of revenue
Net income −USD 1.41 million −154% of revenue

Cash

Operating cash flow −USD 768,000 −84% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2017 Operating loss: operating costs were 106% of revenue.
2018 Operating loss: operating costs were 120% of revenue.
2019 Operating loss: operating costs were 116% of revenue.
2020 Operating loss: operating costs were 115% of revenue.
2021 Operating loss: operating costs were 153% of revenue.
2022 Operating loss: operating costs were 236% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2017 2017-01-01 – 2017-12-31	4914000	5225000 Derived	-311000	234000 Derived	-545000	137000 Derived	Source 2017-01-01 – 2017-12-31: 4914000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -311000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -545000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: 181000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 44000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	3872000	4634000 Derived	-762000	266000 Derived	-1028000	-220000 Derived	Source 2018-01-01 – 2018-12-31: 3872000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -762000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -1028000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -220000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 0 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	3655000	4248000 Derived	-593000	88000 Derived	-681000	58000 Derived	Source 2019-01-01 – 2019-12-31: 3655000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -593000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -681000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: 58000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 0 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	4147000	4768000 Derived	-621000	175000 Derived	-796000	-487000 Derived	Source 2020-01-01 – 2020-12-31: 4147000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -621000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -796000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -483000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 4000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	2218000	3397000 Derived	-1179000	-716000 Derived	-463000	-673000 Derived	Source 2021-01-01 – 2021-12-31: 2218000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -1179000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -463000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -673000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 0 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	913000	2155000 Derived	-1242000	168000 Derived	-1410000	Unavailable	Source 2022-01-01 – 2022-12-31: 913000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -1242000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -1410000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -768000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 913K 2022

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Revenue	4914000	Revenue: 4914000 Open source
20182018-12-31	Revenue	3872000	Revenue: 3872000 Open source
20192019-12-31	Revenue	3655000	Revenue: 3655000 Open source
20202020-12-31	Revenue	4147000	Revenue: 4147000 Open source
20212021-12-31	Revenue	2218000	Revenue: 2218000 Open source
20222022-12-31	Revenue	913000	Revenue: 913000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-58.8% 2022

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Year over year	No prior comparable period	Revenue: 4914000 Open source
20182018-12-31	Year over year	-21.2%	Revenue: 3872000 Open source Revenue: 4914000 Open source
20192019-12-31	Year over year	-5.6%	Revenue: 3655000 Open source Revenue: 3872000 Open source
20202020-12-31	Year over year	13.5%	Revenue: 4147000 Open source Revenue: 3655000 Open source
20212021-12-31	Year over year	-46.5%	Revenue: 2218000 Open source Revenue: 4147000 Open source
20222022-12-31	Year over year	-58.8%	Revenue: 913000 Open source Revenue: 2218000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -136% 2022

Net margin -154.4% 2022

Free cash flow margin -30.3% 2021

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Operating margin	-6.3%	Operating Income: -311000 Open source Revenue: 4914000 Open source
20182018-12-31	Operating margin	-19.7%	Operating Income: -762000 Open source Revenue: 3872000 Open source
20192019-12-31	Operating margin	-16.2%	Operating Income: -593000 Open source Revenue: 3655000 Open source
20202020-12-31	Operating margin	-15%	Operating Income: -621000 Open source Revenue: 4147000 Open source
20212021-12-31	Operating margin	-53.2%	Operating Income: -1179000 Open source Revenue: 2218000 Open source
20222022-12-31	Operating margin	-136%	Operating Income: -1242000 Open source Revenue: 913000 Open source
20172017-12-31	Net margin	-11.1%	Net Income: -545000 Open source Revenue: 4914000 Open source
20182018-12-31	Net margin	-26.5%	Net Income: -1028000 Open source Revenue: 3872000 Open source
20192019-12-31	Net margin	-18.6%	Net Income: -681000 Open source Revenue: 3655000 Open source
2020-12-31	Net margin	Not reported	Revenue: 4147000 Open source
20212021-12-31	Net margin	-20.9%	Net Income: -463000 Open source Revenue: 2218000 Open source
20222022-12-31	Net margin	-154.4%	Net Income: -1410000 Open source Revenue: 913000 Open source
20172017-12-31	Free cash flow margin	2.8%	Revenue: 4914000 Open source Operating Cash Flow: 181000 Open source Capital Expenditure: 44000 Open source
20182018-12-31	Free cash flow margin	-5.7%	Revenue: 3872000 Open source Operating Cash Flow: -220000 Open source Capital Expenditure: 0 Open source
20192019-12-31	Free cash flow margin	1.6%	Revenue: 3655000 Open source Operating Cash Flow: 58000 Open source Capital Expenditure: 0 Open source
20202020-12-31	Free cash flow margin	-11.7%	Revenue: 4147000 Open source Operating Cash Flow: -483000 Open source Capital Expenditure: 4000 Open source
20212021-12-31	Free cash flow margin	-30.3%	Revenue: 2218000 Open source Operating Cash Flow: -673000 Open source Capital Expenditure: 0 Open source
20222022-12-31	Free cash flow margin	Not reported	Revenue: 913000 Open source Operating Cash Flow: -768000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -768K 2022

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Operating cash flow	181000	Operating Cash Flow: 181000 Open source
20182018-12-31	Operating cash flow	-220000	Operating Cash Flow: -220000 Open source
20192019-12-31	Operating cash flow	58000	Operating Cash Flow: 58000 Open source
20202020-12-31	Operating cash flow	-483000	Operating Cash Flow: -483000 Open source
20212021-12-31	Operating cash flow	-673000	Operating Cash Flow: -673000 Open source
20222022-12-31	Operating cash flow	-768000	Operating Cash Flow: -768000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -673K 2021

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Free cash flow	137000	Operating Cash Flow: 181000 Open source Capital Expenditure: 44000 Open source
20182018-12-31	Free cash flow	-220000	Operating Cash Flow: -220000 Open source Capital Expenditure: 0 Open source
20192019-12-31	Free cash flow	58000	Operating Cash Flow: 58000 Open source Capital Expenditure: 0 Open source
20202020-12-31	Free cash flow	-487000	Operating Cash Flow: -483000 Open source Capital Expenditure: 4000 Open source
20212021-12-31	Free cash flow	-673000	Operating Cash Flow: -673000 Open source Capital Expenditure: 0 Open source
20222022-12-31	Free cash flow	Unavailable	Operating Cash Flow: -768000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

284.3% 2022

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Liabilities / assets	78.5%	Total Liabilities: 2268000 Open source Total Assets: 2891000 Open source
20182018-12-31	Liabilities / assets	105.9%	Total Liabilities: 2621000 Open source Total Assets: 2475000 Open source
20192019-12-31	Liabilities / assets	138%	Total Liabilities: 2868000 Open source Total Assets: 2078000 Open source
20202020-12-31	Liabilities / assets	165.2%	Total Liabilities: 3182000 Open source Total Assets: 1926000 Open source
20212021-12-31	Liabilities / assets	150.1%	Total Liabilities: 2827000 Open source Total Assets: 1883000 Open source
20222022-12-31	Liabilities / assets	284.3%	Total Liabilities: 3608000 Open source Total Assets: 1269000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.21× 2022

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Current assets / current liabilities	1.32×	Current Assets: 1954000 Open source Current Liabilities: 1477000 Open source
20182018-12-31	Current assets / current liabilities	0.88×	Current Assets: 1613000 Open source Current Liabilities: 1825000 Open source
20192019-12-31	Current assets / current liabilities	0.73×	Current Assets: 1224000 Open source Current Liabilities: 1687000 Open source
20202020-12-31	Current assets / current liabilities	0.58×	Current Assets: 1180000 Open source Current Liabilities: 2021000 Open source
20212021-12-31	Current assets / current liabilities	0.46×	Current Assets: 1305000 Open source Current Liabilities: 2824000 Open source
20222022-12-31	Current assets / current liabilities	0.21×	Current Assets: 769000 Open source Current Liabilities: 3602000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2014 2014-01-01 – 2014-12-31	−USD 490,000 Exact value Exact value: -490000 USD 2014-01-01 – 2014-12-31: -490000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AMERICAN BIO MEDICA CORP · 2014-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Net Income: -490000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -490000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000114420416091507/abmc-20151231.xml#110810 Filing: 000114420416091507 The citation records this snapshot. The page link may show a newer release later.	USD 98,000 Exact value Exact value: 98000 USD 2014-01-01 – 2014-12-31: 98000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AMERICAN BIO MEDICA CORP · 2014-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Operating Cash Flow: 98000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 98000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000114420416091507/abmc-20151231.xml#113975 Filing: 000114420416091507 The citation records this snapshot. The page link may show a newer release later.	USD 51,000 Exact value Exact value: 51000 USD 2014-01-01 – 2014-12-31: 51000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AMERICAN BIO MEDICA CORP · 2014-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Capital Expenditure: 51000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 51000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000114420416091507/abmc-20151231.xml#120457 Filing: 000114420416091507 The citation records this snapshot. The page link may show a newer release later.	USD 47,000 Calculation and evidence 98000 − 51000 USD Exact free cash flow: 47000 USD 2014-01-01 – 2014-12-31: 98000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 51000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AMERICAN BIO MEDICA CORP · 2014-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Free cash flow: 47000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 98000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000114420416091507/abmc-20151231.xml#113975 Filing: 000114420416091507 Input fundies:CapitalExpenditure: 51000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000114420416091507/abmc-20151231.xml#120457 Filing: 000114420416091507 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 333,000 Exact value Exact value: -333000 USD 2015-01-01 – 2015-12-31: -333000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AMERICAN BIO MEDICA CORP · 2015-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Net Income: -333000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -333000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000114420417018013/abmc-20161231.xml#88330 Filing: 000114420417018013 The citation records this snapshot. The page link may show a newer release later.	USD 230,000 Exact value Exact value: 230000 USD 2015-01-01 – 2015-12-31: 230000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AMERICAN BIO MEDICA CORP · 2015-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Operating Cash Flow: 230000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 230000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000114420417018013/abmc-20161231.xml#99386 Filing: 000114420417018013 The citation records this snapshot. The page link may show a newer release later.	USD 13,000 Exact value Exact value: 13000 USD 2015-01-01 – 2015-12-31: 13000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AMERICAN BIO MEDICA CORP · 2015-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Capital Expenditure: 13000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000114420417018013/abmc-20161231.xml#105665 Filing: 000114420417018013 The citation records this snapshot. The page link may show a newer release later.	USD 217,000 Calculation and evidence 230000 − 13000 USD Exact free cash flow: 217000 USD 2015-01-01 – 2015-12-31: 230000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 13000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AMERICAN BIO MEDICA CORP · 2015-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Free cash flow: 217000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 230000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000114420417018013/abmc-20161231.xml#99386 Filing: 000114420417018013 Input fundies:CapitalExpenditure: 13000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000114420417018013/abmc-20161231.xml#105665 Filing: 000114420417018013 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 345,000 Exact value Exact value: -345000 USD 2016-01-01 – 2016-12-31: -345000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AMERICAN BIO MEDICA CORP · 2016-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Net Income: -345000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -345000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495418003884/abmc-20171231.xml#55809 Filing: 000165495418003884 The citation records this snapshot. The page link may show a newer release later.	USD 241,000 Exact value Exact value: 241000 USD 2016-01-01 – 2016-12-31: 241000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AMERICAN BIO MEDICA CORP · 2016-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Operating Cash Flow: 241000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 241000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495418003884/abmc-20171231.xml#66301 Filing: 000165495418003884 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2016-01-01 – 2016-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AMERICAN BIO MEDICA CORP · 2016-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495418003884/abmc-20171231.xml#69652 Filing: 000165495418003884 The citation records this snapshot. The page link may show a newer release later.	USD 241,000 Calculation and evidence 241000 − 0 USD Exact free cash flow: 241000 USD 2016-01-01 – 2016-12-31: 241000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AMERICAN BIO MEDICA CORP · 2016-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Free cash flow: 241000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 241000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495418003884/abmc-20171231.xml#66301 Filing: 000165495418003884 Input fundies:CapitalExpenditure: 0 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495418003884/abmc-20171231.xml#69652 Filing: 000165495418003884 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 545,000 Exact value Exact value: -545000 USD 2017-01-01 – 2017-12-31: -545000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AMERICAN BIO MEDICA CORP · 2017-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Net Income: -545000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -545000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495419004490/abmc-20181231.xml#59550 Filing: 000165495419004490 The citation records this snapshot. The page link may show a newer release later.	USD 181,000 Exact value Exact value: 181000 USD 2017-01-01 – 2017-12-31: 181000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AMERICAN BIO MEDICA CORP · 2017-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Operating Cash Flow: 181000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 181000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495419004490/abmc-20181231.xml#66922 Filing: 000165495419004490 The citation records this snapshot. The page link may show a newer release later.	USD 44,000 Exact value Exact value: 44000 USD 2017-01-01 – 2017-12-31: 44000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AMERICAN BIO MEDICA CORP · 2017-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Capital Expenditure: 44000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 44000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495419004490/abmc-20181231.xml#67317 Filing: 000165495419004490 The citation records this snapshot. The page link may show a newer release later.	USD 137,000 Calculation and evidence 181000 − 44000 USD Exact free cash flow: 137000 USD 2017-01-01 – 2017-12-31: 181000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 44000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AMERICAN BIO MEDICA CORP · 2017-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Free cash flow: 137000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 181000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495419004490/abmc-20181231.xml#66922 Filing: 000165495419004490 Input fundies:CapitalExpenditure: 44000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495419004490/abmc-20181231.xml#67317 Filing: 000165495419004490 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 1.03 million Exact value Exact value: -1028000 USD 2018-01-01 – 2018-12-31: -1028000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AMERICAN BIO MEDICA CORP · 2018-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Net Income: -1028000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1028000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495420013967/abmc-20200930.xml#108296 Filing: 000165495420013967 The citation records this snapshot. The page link may show a newer release later.	−USD 220,000 Exact value Exact value: -220000 USD 2018-01-01 – 2018-12-31: -220000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AMERICAN BIO MEDICA CORP · 2018-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Operating Cash Flow: -220000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -220000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495420013967/abmc-20200930.xml#118642 Filing: 000165495420013967 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2018-01-01 – 2018-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AMERICAN BIO MEDICA CORP · 2018-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495420013967/abmc-20200930.xml#124486 Filing: 000165495420013967 The citation records this snapshot. The page link may show a newer release later.	−USD 220,000 Calculation and evidence -220000 − 0 USD Exact free cash flow: -220000 USD 2018-01-01 – 2018-12-31: -220000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AMERICAN BIO MEDICA CORP · 2018-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Free cash flow: -220000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -220000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495420013967/abmc-20200930.xml#118642 Filing: 000165495420013967 Input fundies:CapitalExpenditure: 0 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495420013967/abmc-20200930.xml#124486 Filing: 000165495420013967 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 681,000 Exact value Exact value: -681000 USD 2019-01-01 – 2019-12-31: -681000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AMERICAN BIO MEDICA CORP · 2019-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Net Income: -681000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -681000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495421004250/abmc-20201231.xml#64312 Filing: 000165495421004250 The citation records this snapshot. The page link may show a newer release later.	USD 58,000 Exact value Exact value: 58000 USD 2019-01-01 – 2019-12-31: 58000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AMERICAN BIO MEDICA CORP · 2019-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Operating Cash Flow: 58000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 58000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495421004250/abmc-20201231.xml#125748 Filing: 000165495421004250 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2019-01-01 – 2019-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AMERICAN BIO MEDICA CORP · 2019-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495421004250/abmc-20201231.xml#122781 Filing: 000165495421004250 The citation records this snapshot. The page link may show a newer release later.	USD 58,000 Calculation and evidence 58000 − 0 USD Exact free cash flow: 58000 USD 2019-01-01 – 2019-12-31: 58000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AMERICAN BIO MEDICA CORP · 2019-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Free cash flow: 58000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 58000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495421004250/abmc-20201231.xml#125748 Filing: 000165495421004250 Input fundies:CapitalExpenditure: 0 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495421004250/abmc-20201231.xml#122781 Filing: 000165495421004250 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 796,000 Exact value Exact value: -796000 USD 2020-01-01 – 2020-12-31: -796000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AMERICAN BIO MEDICA CORP · 2020-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Net Income: -796000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -796000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495422005014/abmc_10k.htm#604766 Filing: 000165495422005014 The citation records this snapshot. The page link may show a newer release later.	−USD 483,000 Exact value Exact value: -483000 USD 2020-01-01 – 2020-12-31: -483000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AMERICAN BIO MEDICA CORP · 2020-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Operating Cash Flow: -483000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -483000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495422005014/abmc_10k.htm#604998 Filing: 000165495422005014 The citation records this snapshot. The page link may show a newer release later.	USD 4,000 Exact value Exact value: 4000 USD 2020-01-01 – 2020-12-31: 4000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AMERICAN BIO MEDICA CORP · 2020-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Capital Expenditure: 4000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495422005014/abmc_10k.htm#570034 Filing: 000165495422005014 The citation records this snapshot. The page link may show a newer release later.	−USD 487,000 Calculation and evidence -483000 − 4000 USD Exact free cash flow: -487000 USD 2020-01-01 – 2020-12-31: -483000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 4000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AMERICAN BIO MEDICA CORP · 2020-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Free cash flow: -487000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -483000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495422005014/abmc_10k.htm#604998 Filing: 000165495422005014 Input fundies:CapitalExpenditure: 4000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495422005014/abmc_10k.htm#570034 Filing: 000165495422005014 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-02 – 2020-12-31	−USD 796,000 Exact value Exact value: -796000 USD 2020-01-02 – 2020-12-31: -796000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AMERICAN BIO MEDICA CORP · 2020-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Net Income: -796000 USD Concept: fundies:NetIncome Period: 2020-01-02 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-02&unit=USD&dimensions= Input fundies:NetIncome: -796000 USD (2020-01-02 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495422005014/abmc_10k.htm#504175 Filing: 000165495422005014 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2021 2021-01-01 – 2021-12-31	−USD 463,000 Exact value Exact value: -463000 USD 2021-01-01 – 2021-12-31: -463000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AMERICAN BIO MEDICA CORP · 2021-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Net Income: -463000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -463000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495423003260/abmc_10k.htm#592782 Filing: 000165495423003260 The citation records this snapshot. The page link may show a newer release later.	−USD 673,000 Exact value Exact value: -673000 USD 2021-01-01 – 2021-12-31: -673000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AMERICAN BIO MEDICA CORP · 2021-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Operating Cash Flow: -673000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -673000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495423003260/abmc_10k.htm#561791 Filing: 000165495423003260 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2021-01-01 – 2021-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AMERICAN BIO MEDICA CORP · 2021-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495422005014/abmc_10k.htm#569317 Filing: 000165495422005014 The citation records this snapshot. The page link may show a newer release later.	−USD 673,000 Calculation and evidence -673000 − 0 USD Exact free cash flow: -673000 USD 2021-01-01 – 2021-12-31: -673000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AMERICAN BIO MEDICA CORP · 2021-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Free cash flow: -673000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -673000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495423003260/abmc_10k.htm#561791 Filing: 000165495423003260 Input fundies:CapitalExpenditure: 0 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495422005014/abmc_10k.htm#569317 Filing: 000165495422005014 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 1.41 million Exact value Exact value: -1410000 USD 2022-01-01 – 2022-12-31: -1410000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AMERICAN BIO MEDICA CORP · 2022-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Net Income: -1410000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1410000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495423003260/abmc_10k.htm#592058 Filing: 000165495423003260 The citation records this snapshot. The page link may show a newer release later.	−USD 768,000 Exact value Exact value: -768000 USD 2022-01-01 – 2022-12-31: -768000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AMERICAN BIO MEDICA CORP · 2022-12-31 AMERICAN BIO MEDICA CORP (edgar:896747) Operating Cash Flow: -768000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:24:36Z Snapshot: 44963244d171b35a61b483efc9cc8b90f403e9824701af31ad9eda97a266b47e Dimensions: Consolidated View: https://fundies.io/companies/edgar/896747/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -768000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/896747/000165495423003260/abmc_10k.htm#561109 Filing: 000165495423003260 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

129 filings · 3,262 latest values · 3,262 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000896747, 896747, ABMC, abmc, edgar:896747

Also known as AMERICAN BIO MEDICA CORP, AMERICAN BIO MEDICA CORPORATION, American Bio Medica Corporation

AMERICAN BIO MEDICA CORP

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2022 2022-01-01 – 2022-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation